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MaRecent multicenter trials have shown that transcatheter aortic valve replacement is an alternative to surgery in a high
risk population of patients with severe, symptomatic aortic stenosis. Echocardiography and multislice computed
tomographic imaging are accepted tools in the pre-procedural imaging of the aortic valve complex and vascular access.
Transesophageal echocardiography can be valuable for intraprocedural conﬁrmation of the landing zone morphology
and measurements, positioning of the valve and post-procedural evaluation of complications. The current paper pro-
vides recommendations for pre-procedural and intraprocedural imaging used in assessing patients for transcatheter
aortic valve replacement with either balloon-expandable or self-expanding transcatheter heart valves. (J Am Coll
Cardiol Img 2015;8:261–87) © 2015 by the American College of Cardiology Foundation.T ranscatheter aortic valve replacement(TAVR) has become an accepted alternativeto surgical intervention in patients with
severe, symptomatic aortic stenosis who are inoper-
able or at high risk for surgical valve replace-
ment (1–4). Numerous consensus papers and
guidelines suggest that echocardiography is impor-
tant in the pre-procedural, intraprocedural, and
post-procedural evaluation of patients undergoing
TAVR (5–8). Recent studies suggest that intrapro-
cedural transesophageal echocardiographic (TEE)
imaging may not be necessary for the safe place-
ment of the transcatheter heart valve (THV) (9–13).
These reports come from experienced, high-volume
sites however and may not be generalizable to new
programs or low-volume sites. Although no direct
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ABBR EV I A T I ON S
AND ACRONYMS
2D = 2-dimensional
3D = 3-dimensional
BAV = balloon aortic
valvuloplasty
EOA = effective oriﬁce area
ICE = intracardiac
echocardiography
LVOT = left ventricular
outﬂow tract
MSCT = multislice computed
tomography
PAR = paravalvular aortic
regurgitation
RVOT = right ventricular
outﬂow tract
TAVR = transcatheter aortic
valve replacement
TEE = transesophageal
echocardiography
THV = transcatheter
heart valve
TTE = transthoracic
echocardiography
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262not warrant the risk of delayed diagnosis
of catastrophic complications. In addition,
although TEE is typically performed under
general anesthesia, a number of sites perform
TEE for TAVR under conscious sedation
(17). Thus, as we move toward TAVR in the
lower-risk patient population and outcomes
are expected to improve, echocardiography
will likely continue to play an important role
in optimizing TAVR procedural results. The
following are recommendations for compre-
hensive intraprocedural echocardiographic
imaging during TAVR.
BACKGROUND
Current guidelines emphasize a multidisci-
plinary team approach to TAVR (5,18). Echo-
cardiographers are now an important part of
the team and should be involved in every
phase of implantation of a THV from pre-
implantation patient screening, decision
making about appropriate THV size, intra-
procedural guidance of wire and THV posi-tion, and post-implantation assessment. Thus,
echocardiographers should be familiar with pre-
procedural screening requirements, the anatomy of
the aortic valvular complex, the structure of the THVE 1 The Balloon-Expandable Transcatheter Heart Valves
APIEN XT (left) and SAPIEN 3 (right) valves have a cobalt chromiu
ﬂets. The latter frame has wide strut angles and a skirt that exte
THV ¼ transcatheter heart valve.and positioning considerations, the procedural pro-
tocol, and the complications that may occur at each
stage of the procedure.
Three generations of balloon-expandable valves,
ﬁrst generation (SAPIEN), second generation (SAPIEN
XT), and third generation (SAPIEN 3) (Edwards Life-
sciences, Irvine, California) have been implanted
either through large-scale trials or commercial re-
lease. The current commercially available valve, the
second generation balloon-expandable valve (SAPIEN
XT), is composed of 3 symmetric, treated bovine
pericardial leaﬂets, mounted on a cobalt chromium,
balloon-expandable stent (Figure 1). A fabric skirt is
mounted on the inside of the stent below the leaﬂets
that allows the valve to seal at the annulus. The lower
borders of the cusps are located at almost exactly the
middle of the stent with the upper extent of the cusps
reaching the level of the distal stent. This THV is
ideally positioned in a subcoronary location and is
available in 3 sizes (23 mm, 26 mm, and 29 mm) to
treat sagittal plane annular diameters of 18 mm to 27
mm. Algorithms for sizing are based on “oversizing”
the valve (THV larger than native annulus) to ensure
stable seating of the valve, and minimize para-
valvular aortic regurgitation (PAR). The percent
oversizing is determined by the formula: ([nominal
THV area/native cross-sectional annular area] – 1) 
100. For the second generation balloon-expandablem frame with a fabric skirt mounted on the inside of the stent below
nds around the outside of the frame to reduce paravalvular regurgi-
TABLE 1 Proposed Sizing Algorithm Using Annular Area (mm2) for the
Second and Third Generation Balloon-Expandable Valves
Valve Size
20 mm 23 mm 26 mm 29 mm
Nominal area, mm2 314 415 531 661
Annular range for second generation
balloon-expandable valve, mm2
257–310 298–410 420–530 530–660
Annular range for third generation
balloon-expandable valve, mm2
273–345 338–430 430–546 540–683
The nominal areas for each balloon-expandable valve size is listed (in mm2). The ranges of annular
areas that can be covered are based on an acceptable oversizing range of 5% to 20% for the
second generation balloon-expandable valve, and a 5% to 20% oversizing with the third
generation balloon-expandable valve. (Note: a negative oversizing equates to undersizing of the
valve, in which the native annulus can be up to 5% larger than the nominal area of the trans-
catheter valve).
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263valve, the oversizing range is based on the area of
both the THV and the annulus: between 5% and 20%
area oversizing is acceptable. Oversizing of >20%,
however, is associated with annular rupture (19),
leading some authors to suggest using 15% oversizing
as the upper limit, and 20% oversizing only in the
absence of adverse aortic root features (20). Other
authors suggest the solution to appropriate coverage
of the annular sizes between the ideal coverage range
could be intentional underexpansion of a larger THV,
showing no adverse outcomes with this practice
(21,22). The newest iteration the third generation
balloon-expandable valve, has a cobalt chromium
frame designed with wide strut angles that permit a
smaller delivery system. An outer skirt of poly-
ethylene terephthalate covers the lower row of cells
and minimizes paravalvular leak (23,24). In addition
to the 23-mm, 26-mm, and 29-mm valves, there is also
a 20-mm valve that increases the range of sagittal
annular diameters to between 18 mm to 28 mm. The
acceptable oversizing range is between 5%
and þ20%; however, the ideal range may be
between 5% and þ5% because the hemodynamics of
this valve are ideal when the THV is fully expanded
(i.e., not underexpanded) (24). A negative 5% over-
sizing equates to undersizing of the valve, in which
the native annulus can be up to 5% larger than
the nominal area of the transcatheter. Again, using
15% oversizing as the upper limit, and 20%FIGURE 2 The Self-Expanding Transcatheter Heart Valve
Both CoreValve (left) and Evolut R (right) valves have a nitinol frame wit
fully recapturable and repositionable and is approximately 5 mm shorteoversizing only in the absence of adverse aortic root
features, seems prudent. A proposed sizing algorithm
for the second generation balloon-expandable valve
and third generation balloon-expandable valve is
listed in Table 1.
The self-expanding valve (CoreValve ReValving
System, Medtronic, Minneapolis, Minnesota) is a
porcine pericardial valve, mounted within a self-
expanding nitinol frame with a diamond cell design
(Figure 2). The frame has 3 dedicated zones that
allow proper orientation, anchoring, and valve
placement. Each zone has different radial and hoop
strengths. A skirt is mounted inside the frame
covering the lower 12 mm of the valve except at theh a 12-mm fabric skirt mounted on the inside of the stent; the latter is
r in height. THV ¼ transcatheter heart valve.
TABLE 2 Manufacturer’s Recommended Sizing Algorithm for the
Self-Expanding Valve
Annular Dimension
Valve Size
23 mm 26 mm 29 mm 31 mm
Mean diameter range, mm 18–20 20–23 23–27 26–29
Perimeter range, mm 56.5–62.8 62.8–72.3 72.3–84.8 81.7–91.1
Area range, mm2 254.5–314.2 314.2–415.5 415.5–572.6 530.9–660.5
For the self-expanding valve, the mean annular diameter and perimeter oversizing ranges from
7% to 30%. The annular area oversizing ranges from 7% to 69% according to the manufacturer
(see Achenbach et al. [25]).
TABLE 3 Pre-Procedural Transthoracic Assessment
Pre-Procedural Echocardiographic Imaging
Aortic valve and root
Aortic valve morphology
Bicuspid versus tricuspid
Degree and location of calcium
Annular dimensions
Minimum and maximum diameters
Perimeter
Area
Aortic valve hemodynamics
Aortic valve gradients and area
Stroke volume
Impedance
Left ventricular outﬂow tract
Extent and distribution of calcium
Presence of sigmoid septum
Aortic root dimensions and calciﬁcation
Sinus of Valsalva diameter
Sinotubular junction diameter and calciﬁcation
Location of coronary ostia and risk of obstruction
Mitral valve
Severity of mitral regurgitation
Presence of mitral stenosis
Severity of ectopic calciﬁcation
Anterior leaﬂet calciﬁcation
Left ventricular size and function
Wall motion assessment
Exclude intracardiac thrombus
Left ventricular mass
Hypertrophy and septal morphology
Assessments of function
Ejection fraction
Strain and torsion
Diastolic function
Right heart
Right ventricular size and function
Tricuspid valve morphology and function
Estimate of pulmonary artery pressures
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264lowest half-diamond edge (leaving 4 mm of inter-
mittent skirt coverage). The valve is intended to seat
in a supra-annular position. The self-expanding
valve is self-centering and partially repositionable,
and available in 4 sizes (23 mm, 26 mm, 29 mm, and
31 mm) to treat mean annular diameters of 18 mm to
29 mm. The frame height is 55 mm, and the out-
ﬂow end sits in the ascending aorta. The second
generation self-expanding transcatheter aortic valve
(Evolut R system, Medtronic), now CE-mark ap-
proved in Europe and in trial in the United States,
has a true 18-F outer diameter deliver system, a
lower frame height of 45 mm, and is fully recaptur-
able and repositionable. The speciﬁc recommenda-
tions for sizing the self-expanding valve are listed in
Table 2. In general, the goal is a perimeter oversizing
of between 10% and 15%; however, up to 30%FIGURE 3 Biplane Imaging of the Aortic Valve Is Used to Correctly Align the LAX View for Measurement of the Aortic Annulus
In this transesophageal echocardiography (TEE) simultaneous biplane image, the yellow dotted line indicates the plane of the orthogonal view.
The short-axis plane (A) bisects the largest annular dimension. In the long-axis (LAX) plane (B), the annulus is measured at the hinge point of
the right coronary cusp anteriorly (green arrow). The virtual annulus (red arrow) is measured as a plane perpendicular to the long axis of the
aorta (white dotted line).
FIGURE 4 Direct Planimetry of the Annular Plane
Using user-deﬁned (zoom) 3-dimensional volumes, direct planimetry of the annulus using
multiplanar reconstruction can be performed. In this example, the systolic short-axis plane
(red box) is identiﬁed by using the orthogonal long-axis views. The annular area of
414 mm2 would suggest a 23-mm second generation balloon-expandable valve or a 26-
mm self-expanding valve could be used.
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265oversizing is frequently acceptable (25). Importantly,
perimeter oversizing differs from area oversizing
because for a circular annulus, perimeter increases
proportional with and area increases exponentially
with an increase in nominal diameter. This rela-
tionship is more complex with noncircular geometry
(26). In addition to annular dimensions, the sinus of
Valsalva diameter should be $27 mm for the 26-mm
valve and $29 mm for the 29- and 31-mm valves.
The ascending aorta diameter should be #40 mm
for the 26-mm valve and #43 mm for the 29- and
31-mm valves for the self-expanding valve however
these restrictions may not apply for the shorter
second generation self-expanding transcatheter
aortic valve.
A number of other valves are in varying stages of
development and will likely be available for implan-
tation in the near future. Although many comments
in this review are valve neutral, valve-speciﬁc com-
ments are limited to both families of valves.
PRE-PROCEDURAL ECHOCARDIOGRAPHIC
IMAGING
The pre-procedural transthoracic echocardiogram
(TTE) involves a comprehensive evaluation of val-
vular morphology and function as well as ventricular
size and function (Table 3). The general approach
to assessing aortic stenosis, aortic regurgitation,
and mitral regurgitation is detailed in the American
Society of Echocardiography guidelines (7,27); a few
key points deserve emphasis in the technically chal-
lenging TAVR population.
AORTIC VALVE COMPLEX. The aortic valve complex
includes the left ventricular outﬂow tract (LVOT),
composed of the basal ventricular septum and the
subaortic mitral valve curtain, the aortic annulus, the
aortic valve cusps, the sinuses of Valsalva, and the
sinotubular junction. Annular sizing, as well as char-
acterization of the periannular region (cusps, LVOT,
and proximal aortic root), improves anticipation and
avoidance of complications such as paravalvular
regurgitation, left main occlusion, or annular rupture
(19,28–30).
Aortic annulus. The most important measurement
currently used for THV sizing is the “annulus,” which
is a virtual plane at the level of the hinge point (lowest
attachment site) of the 3 cusps (31). Between these
hinge points and scalloped aortic leaﬂets is the ﬁbrous
tissue of the interleaﬂet trigones. Measurement of the
diameter of this virtual ring is thus difﬁcult because:
1) with a tricuspid aortic valve, any long-axis plane
bisecting a cusp hinge point on one side will not image
a hinge point on the other side, but rather a region ofﬁbrous tissue between the scalloped cusps; and 2) the
annulus is often asymmetric and oval, with annular
diameters largest in the coronal plane and shortest in
the sagittal plane (32–34).
The traditional measurement for sizing the
annulus has been the systolic diameter in the long-
axis (sagittal) plane. Although this is no longer
used for sizing, historically, this measurement was
adequate in the majority of cases: 1) as long as
appropriate oversizing algorithms were used (30);
2) the measurement was performed in systole; and
3) the measurement was performed from an appro-
priate imaging window. Because of the dynamic na-
ture of the annular shape, which becomes less
elliptical (i.e., more round) in systole (35), measure-
ments in this part of the cardiac cycle typically yield
a larger measurement than in diastole. The correct
long-axis imaging window should bisect the
maximum diameter of the aorta, and simultaneous
multiplane imaging using 3-dimensional (3D) tech-
nology allows imaging of both the short-axis and
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266long-axis planes to ensure imaging of the correct
plane (Figure 3). The right coronary cusp hinge point
is imaged anteriorly, and the ﬁbrous interleaﬂet
trigone posteriorly. Because there is no anatomic
marker for the virtual annular plane within the
interleaﬂet trigone, the correct annular diameter is
measured by assuming the virtual annulus is
perpendicular to the long axis of the aorta. Calciﬁ-
cation of the scalloped lines of leaﬂet attachment
within the sinuses (and deﬁning the borders of the
interleaﬂet trigone) should not be mistaken for the
hinge point of the aortic cusp. Although the sagittal
plane annular diameter cannot be the sole measure-
ment used for valve sizing, the measurement can still
be used as an initial conﬁrmation of THV size
because it typically represents the shorter dimension
of the oval annulus. In addition, these imagingFIGURE 5 Indirect Planimetry of the Annular Plane
Using the orthogonal long-axis views to identify the annular plane in pai
be measured without the hand-tracing errors of direct planimetry. From
the maximum diameter ¼ 26.3 mm, and the annular area ¼ 485 mm2 favo
or a 29 mm self-expanding valve should be used.caveats remain relevant for optimizing LVOT mea-
surements used in the continuity equation.
Multislice computed tomography (MSCT) annular
perimeter or area measurements have repeatedly
been shown to improve the accuracy of THV sizing
algorithms (32–38) and has become the standard im-
aging modality to measure the aortic annulus and
characterize the landing zone. Although MSCT can
provide a quantitative characterization of calcium
and highly reproducible measures of annular geom-
etry, the method does have limitations. Exposure to
radiation is generally of minor concern to current
TAVR populations but may become increasingly
important as younger patients are considered. Renal
dysfunction and the need for intravenous contrast are
common concerns for MSCT protocols. Measuring the
annulus in the short-axis view requires smoothingred orthogonal points, the short axis of the annulus (blue square) can
the same 3D volume as Figure 4, the minimum diameter ¼ 24.2 mm,
ring the use of a 26 mm second generation balloon-expandable valve
FIGURE 6 LVOT Versus Annular Measurements
The left ventricular outﬂow tract (LVOT) (blue dotted line)
should be measured in systole, just apical to the annulus
(red solid line). Although only the anterior leaﬂet (right coronary
cusp) hinge point is seen, assuming the annulus or LVOT is
perpendicular to the long axis of the aorta (white dotted line)
permits an accurate measurement of the LVOT.
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267algorithms to reduce overestimation of perimeter
measurements. Gating and motion artifacts also
reduce the accuracy of this method.
Multiple studies suggest that 3D TEE can also
accurately measure the annular aortic annulus
(39–44), that 3D TEE methods are highly reproducible
and compare favorably to an MSCT standard (45,46),
and can aid in the prediction of and management of
complications (37,46). Altiok et al. (34) showed high
agreement between 3D TEE and MSCT for coronal
diameters (23.60  1.89 mm vs. 23.46  2.07 mm)
and sagittal diameters (22.19  1.96 mm vs. 22.27 
2.01 mm) with high correlation. Khalique et al. (46)
showed similar high agreement and correlation with
3D TEE and MSCT measurements of annulus perim-
eter (74.8  7.0 mm vs. 75.8  6.6 mm) and area
(434.9  81.3 mm2 vs. 442.8  78.9 mm2). Advantages
of the 3D technique include real-time imaging of the
hinge points and elimination of hand-tracing errors
of direct planimetry. Nonetheless, neither 3D echo-
cardiographic technique described in the following
text can overcome the limitations of ultrasound
physics that creates blooming and side-lobe artifacts,
as well as acoustic dropout. In addition, these tech-
niques require expertise and practice.
TEE is typically used to acquire 3D-volume data-
sets, from which the annulus can be measured.
Currently, 2 manual methods can be used: direct
planimetry of the annulus and indirect planimetry.
The ﬁrst uses commercially available software
packages that manipulate the 3D volume using a
multiplanar approach (Figure 4). The short-axis
(transverse) annular plane is obtained using the
orthogonal long-axis views (sagittal and coronal) as a
guide, and the annulus is directly measured for area,
or the minimum and maximum diameters can be
measured (47). Using this method, Jilaihawi et al. (45)
showed that 3D TEE signiﬁcantly underestimated
MSCT measurements of the aortic annulus but was
better than 2-dimensional (2D) TEE in predicting
signiﬁcant paravalvular regurgitation. The second
method of measuring the annulus avoids direct
planimetry of the transverse plane, thus eliminating
hand-tracing errors and allowing the use of anatomic
structures in the long-axis planes to identify the
annulus. This indirect planimetry method uses
vendor-speciﬁc software originally designed for the
mitral valve (Figure 5) and “tricks” the program into
measuring the aortic annulus instead of the mitral
annulus (39). This method has inherent advantages
over direct planimetry: using the long-axis planes
allows the use of anatomic structures, such as the
mitral leaﬂet, aortic root, and septum, to help deﬁne
the annulus; acoustic noise (side lobes) areidentiﬁable on the long-axis images and not mistaken
for the annulus; and acoustic shadowing can be
managed using the short-axis annular plane as a
reference and making sure to keep the annular points
consistent with their neighboring points and reﬂec-
tive of the shape of the “virtual” annulus. Validation
of this method has been described in the preceding
text with no signiﬁcant difference in area and
perimeter measurements compared with MSCT (46).
In the examples shown (Figure 4), the same 3D TEE
volume has been used to measure the annulus by
direct planimetry and indirect planimetry (Figure 5).
The difference in annular measurements is clinically
signiﬁcant, with direct planimetry underestimating
the indirect planimetry method.
Echocardiography may offer some advantages over
MSCT. Multiple cardiac cycles can be analyzed and
the results averaged. This is not the case with MSCT,
which typically is a composite image of multiple
cardiac cycles, limiting its use in patients with sig-
niﬁcant arrhythmias and leading to the generation of
step artifacts or motion. Real-time imaging of the
hinge points and elimination of hand-tracing errors of
direct planimetry are also signiﬁcant advantages to
FIGURE 7 Measurement of the Left Main Coronary Height
Measurement of the left main coronary height using 3-dimensional (3D) transesophageal echocardiography (TEE) is shown using multiplanar
reconstruction. The left main can be identiﬁed in the short-axis view (A, green arrow) by ﬁnding the level of the left main from the long-axis
view (B, green dotted line). The orthogonal coronal long-axis view (C) then displays the left main (green arrow) with the plane of the annulus
(blue dotted line). From this view, the height of the left main above the annulus (LMain) (C, red arrow [D1]) as well as the length of the left
coronary cusp (LCC) (C, yellow arrow [D2]). The sinus of Valsalva (SOV) (B, white arrow) diameter of 34.5 mm suggests the risk of coronary
obstruction is low.
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268the 3D echo technique. Although echocardiographic
imaging (whether 2D or 3D) may be limited by
blooming and side-lobe artifacts, as well as acoustic
dropout, MSCT also suffers from artifacts generated
by annular and valve calciﬁcation. Consequently,
these techniques require expertise and practice.
Advances in software packages are currently being
developed that should automate acquisition and
reduce interobserver variability of echocardiographic
measurement of the aortic annulus.
Left ventricular outﬂow tract. Calculation of the aortic
valve effective oriﬁce area (EOA) by continuity
equation requires an accurate measurement of the
LVOT diameter at the same level used for pulsed
Doppler derivation of the velocity time integral,
because the 2 are combined to calculate strokevolume. In patients with aortic stenosis, the LVOT
sample volume should be placed apical to the region
of ﬂow convergence with the result that the LVOT
systolic diameter should be measured #0.5 cm apical
to the aortic annulus and typically within 1 to 2 mm of
the annular plane, avoiding measurements that are
too apically positioned, particularly in the setting of a
sigmoid septum (Figure 6). The systolic LVOT diam-
eter is frequently 1 to 2 mm smaller than the annular
diameter. A difference of >2 mm should raise the
possibility of incorrect measurement of either
the LVOT or annulus. Basal septal hypertrophy may
be seen in up to 25% of patients with aortic stenosis
and confounds the accurate measurement of the
LVOT. In these patients, LVOT measurement should
be closer to the annulus and avoid the septal bulge.
TABLE 4 Summary of Intraprocedural Imaging Recommendations
Procedural Step Imaging Recommendations
Pacing wire position 1. Conﬁrm position in the right ventricle.
2. Exclude perforation and pericardial effusion.
Stiff wire position 1. Imaging of wire: ensure stable position in the apex without entanglement in mitral apparatus/worsening
mitral regurgitation.
2. Exclude perforation and pericardial effusion.
BAV 1. Image during and immediately following BAV for aortic leaﬂet motion and aortic regurgitation.
2. Image the coronary arteries (particularly the left main) for obstruction by the calciﬁed leaﬂets.
3. Image the location of the displaced calciﬁed leaﬂets for possible deformation of the aortic wall or risk
for annular rupture.
Positioning of transcatheter
valve
1. Balloon-expandable valve:
a. Second generation balloon-expandable valve: inﬂow (i.e. proximal or ventricular) edge of the
THV should be 5 to 6 mm below the annulus. Optimal ﬁnal position isw2 mm below the annulus and
covers the native leaﬂets.
b. Third generation balloon-expandable valve: outﬂow (i.e. distal or aortic) edge of the THV should
cover the native leaﬂets while being below the STJ. Optimal ﬁnal position covers the native leaﬂets.
2. Self-expanding valve:
a. Self-expanding valve: Higher edge of the stent (posterior typically) should be 4 to 5 mm below
the annulus. Optimal position is <10 mm below the annulus to avoid conduction disturbance.
b. Second generation self-expanding transcatheter aortic valve: Higher edge of the stent should be 3–
5 mm below the annulus.
Transapical cannulation 1. Conﬁrm location of the transapical puncture site by imaging the apex (either from mid-esophageal views
or transgastric views). Optimal position will avoid the right ventricle, and be angulated away from the
interventricular septum.
Post-deployment 1. Assess stent positioning, shape, and leaﬂet motion; perform comprehensive hemodynamic measure-
ments including effective oriﬁce area.
a. New LVOT diameter can be the outer-to-outer stent diameter at the inﬂow edge if well positioned, or
inner-to-inner stent diameter at the level of the leaﬂets if THV is too low.
b. Match the velocity-time integral for the location of the LVOT diameter measurement.
2. Assess paravalvular regurgitation relying on short-axis images of the LVOT just apical to the inﬂow edge
of the THV (and gastric views for conﬁrmation).
3. Assess coronary artery patency and ventricular function; conﬁrm ventricular size and function are
similar to baseline or improved.
4. Assess mitral valve morphology and function.
5. Assess TR velocities and estimate pulmonary artery pressures.
6. Exclude perforation and pericardial effusion.
BAV ¼ balloon aortic valvuloplasty; LVOT ¼ left ventricular outﬂow tract; STJ ¼ sinotubular junction; THV ¼ transcatheter heart valve; TR ¼ tricuspid regurgitation.
TABLE 5 Complications of TAVR
Transesophageal Echo Assessment
Hemodynamic instability
Severe transvalvular or paravalvular
aortic regurgitation
 Assess location of regurgitation (central vs. paravalvular).
 Assess position of the transcatheter valve.
 Assess severity of aortic regurgitation.
Severe mitral regurgitation  Evaluate severity of mitral regurgitation and anatomy of the mitral apparatus:
valvular perforation, rupture chordae, tethering of the leaﬂets.
Pericardial effusion  Assess for tamponade physiology and possible etiology (i.e., chamber
perforation, aortic dissection).
Ventricular dysfunction  Evaluate for regional or global wall motion abnormalities of the LV or RV.
 Identify the coronary ostium; use color ﬂow Doppler to assess blood ﬂow.
Aortic rupture or dissection  Examine the aortic root/ascending aorta for periaortic hematoma, aortic
dissection, or rupture.
 Assess for pericardial effusion/tamponade.
Major bleeding  Assess ventricular size and function (wall collapse due to hypovolemia).
Other procedural complications
Balloon aortic valvuloplasty complication  Assess severity of aortic regurgitation.
 Examine the aortic root/ascending aorta for periaortic hematoma, aortic
dissection, or rupture.
 Identify the left main ostium; use color ﬂow Doppler to assess blood ﬂow.
Mal-positioning of the transcatheter heart valve  Too high or too low within the annulus with resulting hemodynamic
instability: rapid deployment of a second valve can be performed.
 Embolization of the valve (into the LV or into the aorta) may require
surgical intervention.
Fistula  Ventricular septal defect.
 Aortocameral ﬁstula (typically into the RVOT or right atrium).
LV ¼ left ventricle; RV ¼ right ventricle; RVOT ¼ right ventricular outﬂow tract; TAVR ¼ transcatheter aortic valve replacement.
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270Numerous studies have shown that the LVOT is
often elliptical (48–50) with the long-axis (sagittal)
plane diameter, thus leading to an underestimation
of the true LVOT area. Studies comparing standard
2D linear measurements to 3D planimetry of LVOT
area show a 10% to 23% underestimation of cardiac
output (51) or EOA using 2D TTE or TEE modalities
(52,53). Thus some sites use 3D echocardiography
to planimeter the area of the LVOT. Despite this
ﬁnding, an EOA <1.0 cm2 calculated by traditional
methods is associated with higher mortality (risk ra-
tio: 1.78; 95% conﬁdence interval: 1.33 to 2.35; p <
0.001) even without symptoms (risk ratio: 1.65; 95%
conﬁdence interval: 1.05 to 2.47; p ¼ 0.02) (54). Cur-
rent American Heart Association/American College
of Cardiology guidelines (55) continue to advocate
the use of standard echocardiographic measurements
of aortic stenosis severity (7).
Communication between the echocardiographer
and other TAVR team members about the qualitative
features of the LVOT and septal geometry are criti-
cally important. Marked basal septal hypertrophyFIGURE 8 The Position of the Wires Can Be Conﬁrmed by TEE
In A, the extra-stiff wire for a transfemoral balloon-expandable THV case
B, the extra-stiff wire for a transapical case is well-positioned across th
dotted arrow). In C, the pacing wire is well positioned at the right vent
transfemoral self-expandable THV case is poorly positioned, wrapped ar
(yellow dotted arrow). AV ¼ aortic valve; LV ¼ left ventricle; MV ¼ mimay complicate accurate positioning and deploy-
ment of the THV because of prominent angulation of
the LVOT and difﬁculty in maintaining coaxial
alignment of the guidewire, sheath, and valve de-
livery catheter. This may be particularly apparent
during the transapical approach when the apical
cannula position is ﬁxed. In addition, a hyper-
dynamic hypertrophied septum may cause the THV
to be superiorly displaced during balloon inﬂation or
unsheathing of the valve. On the other hand, a
markedly thin membranous septum, particularly
with dystrophic calciﬁcation, may also lead to com-
plications such ventricular septal defect (56). Cal-
cium within the LVOT is also an important predictor
of post-TAVR PAR (57,58) as well as annular rupture
(19).
Aortic valve. Valve anatomy, severity and location of
calciﬁcation, as well as the symmetry of valve open-
ing should be assessed. The extent and distribution
of calcium can impact procedural success and has
been associated with excessive THV motion during
deployment (59) and paravalvular regurgitationis well positioned at the left ventricular apex (blue dotted arrow). In
e aortic valve with no entanglement in the mitral apparatus (green
ricular apex (red dotted arrow). In D, the extra-stiff wire for a
ound the base of the heart and entangled in the mitral apparatus
tral valve.
FIGURE 9 Imaging the Transapical Approach for TAVR
The correct position of the apical cannula is determined by visualizing the surgeon’s ﬁngers
as they indicate their intended puncture site (A, blue arrows). Once the apex has been
punctured, advancement of the guidewire should be observed (B, yellow arrows) and
changes in mitral morphology or regurgitation (C) conﬁrmed. Ant ¼ anterior left ventri-
cular wall; AO ¼ aortic root; Inf ¼ inferior left ventricular wall; TAVR ¼ transcatheter aortic
valve replacement.
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271(58,60–62). Bulky calcium increases the risk of calciﬁc
nodule displacement into the coronary ostia, annular
rupture, root perforation, aortic wall hematoma, and
aortic dissection (19,63,64).
An extreme example of asymmetry of valve open-
ing is the bicuspid aortic valve. Two reports of TAVR
in a series of bicuspid aortic valve patients have
shown that, compared with matched trileaﬂet aortic
valve patients, there was no difference in acute pro-
cedural success, valve hemodynamics, or short-term
survival (65,66). However, numerous case reports of
THV implantations in patients with congenitally
abnormal aortic valves (67–69) have limited the use of
TAVR in this population because of reports of signif-
icant aortic regurgitation or suboptimal ﬂow charac-
teristics. The most recent multicenter retrospective
analysis of 139 patients showed a procedural mortal-
ity of 3.6%, with THV embolization in 2.2% and con-
version to surgery in 2.2% (70). Procedural mortality
thus is higher than previous reports of TAVR in tri-
leaﬂet valves with the balloon-expandable THV
(0.9%), although THV embolization and surgical
conversion rates are comparable (2). A higher inci-
dence of PAR grade $2 is also reported for bicuspid
valves: 28.4% overall, and 17.4% when MSCT-based
THV sizing is used. There was no difference in PAR
between self-expanding and balloon-expandable
valves (p ¼ 0.99). Using the bicuspid aortic valve
grading scheme by Sievers et al. (71), there was also
an increased rate of post-implantation aortic regur-
gitation observed in patients with type 1 bicuspid
aortic valve (a single raphe) compared with those
with type 0 or no raphe (34.2% vs. 13.3%, respec-
tively; p ¼ 0.03) (70). This may be related to the bulky
calcium along the raphe preventing adequate appo-
sition of the stent with the LVOT.
Aortic root. The safe, successful deployment of a THV
requires a comprehensive evaluation of the “landing
zone.” The diastolic sinus of Valsalva diameter and
height, diastolic diameter of the sinotubular junction,
as well as the systolic left main coronary artery po-
sition may inﬂuence the size of THV selected as well
as decisions about valve placement. The location of
the coronary ostia is of primary importance because
occlusion can lead to catastrophic left ventricular
dysfunction. Complications associated with right
coronary artery occlusion are signiﬁcantly less
frequent than with left coronary artery occlusion. A
meta-analysis of 18 studies showed that coronary
obstruction occurred from displacement of the calci-
ﬁed left coronary cusp (and not typically from the
stented THV) and the factors associated with coro-
nary obstruction following TAVR include: female
sex, small aortic root diameter (mean diameter27.8  2.8 mm), and low-lying coronary artery (mean
height 10.3  1.6 mm) (29).
Although MSCT is often used for these measure-
ments (72,73), 3D TEE imaging allows rapid acquisi-
tion of the coronal plane for measurement of the
systolic annulus-to-left main distance as well as the
FIGURE 10 Diagno
Imaging the balloon
be used to conﬁrm a
left main coronary a
(red arrow). In this c
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272length of the left coronary cusp during the procedure
(Figure 7). Comparisons of 3D TEE and MSCT mea-
surements of left coronary artery height above the
annulus have shown a high agreement (13.47 
1.67 mm vs. 13.64  1.82 mm) with better correlation
than between angiography andMSCT (34). In addition,
real-time imaging of the left coronary ostium during
balloon aortic valvuloplasty (BAV) or during the TAVR
procedure itself, may help predict and avoid coronary
obstruction.
INTRAPROCEDURAL
ECHOCARDIOGRAPHIC IMAGING
Transesophageal echocardiography is typically used
for intraprocedural imaging. Recommendations for
intraprocedural imaging are summarized in Table 4.
Before THV deployment, a comprehensive TEE as
recommended by the American Society of Echocar-
diography (16) should be performed. This protocol
allows for the full morphological and hemodynamicstic BAV
aortic valvuloplasty (BAV) using simultaneous multiplane imaging can
nnular dimensions (A) (Online Video 1) or to observe the oriﬁce of the
rtery (B, yellow arrow) and the calciﬁed tip of the left coronary cusp
ase, there was no occlusion of the left main coronary oriﬁce seen.assessment of all 4 valves, as well as the 4 chambers.
In addition, pre-implant imaging is used to conﬁrm
the annular diameter and evaluate the aortic valve
complex, assess the valve and root during and
following balloon aortic valvuloplasty, and assist in
catheter and THV positioning. Following THV
deployment, TEE imaging provides rapid and accu-
rate assessment of valve position, valve shape, leaﬂet
motion, and transvalvular gradients. In addition, the
etiologies of hemodynamic compromise can be
rapidly assessed (Table 5): acute valvular dysfunction
(aortic or mitral regurgitation), tamponade physi-
ology (chamber perforation or annular rupture),
ventricular dysfunction (acute coronary obstruction
or ischemic dysfunction), and aortic root catastrophe
(aortic dissection or rupture).
PRE-TAVR DEPLOYMENT TEE IMAGING. For intra-
procedural imaging, a 3D-capable TEE machine is
strongly recommended, but not required. If a pre-
procedural TEE was not performed, then a compre-
hensive TEE protocol is completed with attention to
the above measurements. At a minimum, a qualita-
tive assessment of mitral regurgitation is performed.
Changes in the severity of mitral regurgitation may
indicate mechanical compromise of the mitral appa-
ratus from stiff wires, cannulae, or the THV itself,
left ventricular dysfunction (particularly following
pacing), systolic anterior motion following the
abrupt reduction in afterload that occurs with valve
deployment, increases in blood pressure, or severe
aortic regurgitation. A full evaluation of the aorta,
including the location, size, and mobility of
atheroma, is performed. Left and right ventricular
size and function must be accurately assessed;
although either no change or improvement in func-
tion is typically observed, an acute reduction in left
ventricular or right ventricular function may be a clue
to coronary artery compromise during the procedure.
Quantitation of right ventricular stroke volume is
attempted in order to aid in the ﬁnal assessment of
aortic regurgitation. This quantitation is performed
by measuring the right ventricular outﬂow tract
(RVOT) diameter from 2 imaging planes (mid-esoph-
ageal view at 50 to 70 and deep-gastric view) and
obtaining appropriately aligned pulsed Doppler trac-
ings of RVOT ﬂow. Deep gastric views of the aortic
valve are crucial, allowing accurate Doppler calcula-
tion of EOA by continuity equation and presence,
location, and severity of aortic regurgitation.
A baseline evaluation of left ventricular regional
function should be performed because a peripro-
cedural ischemic event will result in new wall
motion abnormalities. In addition, left ventricular
FIGURE 11 Imaging for Balloon-Expandable THV Positioning
Two-dimensional (2D) imaging of the transcatheter heart valve (THV)/balloon complex is performed for positioning of the valve. The valve (þ)
can typically be distinguished from the balloon although valvular calciﬁcation may cause acoustic shadowing. With the Retroﬂex3 device, the
valve should be positioned with the annulus in the center of the valve during native rhythm. (A) shows the valve (aortic edge of the THV at the
yellow arrows, ventricular edge at the red arrows) slightly low (into the left ventricle), and (B) shows the valve in optimal position just before
pacing. The blue dashed line represents the annulus. During pacing (C and D), the valve moves superiorly (toward the aorta) and is now
positioned with 5 to 6 mm of the THV below the native annulus. Live 3-dimensional (3D) imaging may also be helpful (D) (Online Video 2) if the
edges of the THV cannot be aligned on 2D imaging. Deployment of the second generation balloon-expandable valve can be seen in
Online Video 3.
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273thrombus should be excluded (an absolute contrain-
dication) and left atrial thrombus (including within
the appendage) is considered a relative contraindi-
cation and may require the use of a distal protection
device during the procedure.
WIRE AND CANNULATION POSITION. Occasionally
the position of the pacing wire must be conﬁrmed;
ideally, the tip is in the right ventricular apex.
Following any wire placement into the heart, perfo-
ration and accumulation of pericardial effusion
should be excluded. The position of the retrograde
stiff wire within the left ventricle can also easily be
assessed by echocardiography (Figure 8) with the
J-wire coiled at the apex of the ventricle for stability.
Wire entrapment within the mitral apparatus may
affect the positioning and stability of the balloon orTHV and may cause mitral regurgitation; 2D and 3D
imaging may be particularly useful when this
complication is suspected.
The transapical TAVR approach requires additional
imaging. Because of the small apical window gener-
ated by the limited thoracotomy, imaging of the left
ventricular apex (mid-esophageal view) is useful to
ensure optimal location of the apical puncture
(Figure 9). A cannulation site in the anterior apex al-
lows for appropriate axial alignment of the THV and
avoids the mitral valve apparatus, ventricular
septum, or right ventricular free wall. Echocardio-
graphic (2D or 3D) location of the puncture site by
imaging while the surgeon externally pushes on the
left ventricle at the proposed cannulation site is
useful in ensuring the entry site is optimal.
Frequently, the location of the apical puncture is
FIGURE 12 Positioning of the Third Generation Balloon-Expandable Valve
Positioning of the third generation balloon-expandable valve is less complicated because the valve shortens only from the ventricular end. In this series of images during
deployment of the third generation balloon-expandable valve transcatheter heart valve (THV), the outﬂow (aortic) end (yellow arrow) remains stable (in the same
position) as the inﬂow (ventricular) end (red arrow) shortens. To ensure optimal position, the outﬂow end of the crimped THV should cover the native leaﬂets but remain
1 to 2 mm below the sinotubular junction (Online Video 4).
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274dictated by the coronary artery anatomy or abnormal
positioning of the heart relative to the thoracotomy.
During needle insertion, advancement of the
guidewire/extra-stiff wire, and subsequent apical
cannulation, 2D and color Doppler imaging of the
mitral valve should be performed to ensure anatomic
integrity of the valve and absence of subvalvular
interference.
BALLOON AORTIC VALVULOPLASTY. BAV is often
performed before TAVR to increase cusp excursion
and ensure adequate cardiac output during THV
positioning. Imaging during and following BAV is
important to assess the functional results of the
dilation and possible adverse events. During BAV, thesimultaneous multiplane imaging mode is frequently
utilized with imaging of the mid-esophageal long-axis
and short-axis views of the aortic valve. Because of
the rapid pacing that precedes the BAV, it may be
useful to increase the loop capture by increasing the
number of beats or setting to time capture (5 to 8 s is
usually sufﬁcient).
BAV can be used diagnostically for both conﬁrma-
tion of annular sizing, as well as prediction of calcium
displacement during ﬁnal THV deployment (Online
Video 1) (47,74,75). Imaging the balloon inﬂation
with or without color Doppler imaging (depending on
the frame rates achieved) can be performed for THV
sizing (Figure 10A). Imaging in the short-axis view at
the level of the left main coronary artery may also be
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275a useful diagnostic test to predict left coronary oc-
clusion by a calciﬁed left coronary cusp during THV
deployment (Figure 10B).
Complications from BAV occur in up to 16% of pa-
tients (76) and echocardiographic imaging can help
diagnose acute coronary occlusion, severe aortic
regurgitation, and tamponade. In addition, the
mobility of the cusps should be increased enough to
facilitate THV positioning.
BALLOON-EXPANDABLE THV POSITIONING. It is
critically important to precisely position the THV, and
although ﬂuoroscopy plays a central role (59), TEE
can be used as adjunctive imaging, possibly obviating
the need for contrast injection during deployment. A
pigtail catheter is usually positioned in the right
coronary cusp. Although standard positioning can
usually be performed with optimal placement of the
valve 1 to 2 mm below the annular plane, each case
must be individualized depending on the size of the
THV, anatomy of the aortic root, and position of the
left main coronary artery. The crimped stent can
usually be differentiated echocardiographically from
the underlying balloon (Figure 11) by angulating the
transducer to identify an echo-dense, sharp-edged
structure (as opposed to the heterogeneous appear-
ance of the underlying deﬂated balloon). Because
the acoustic density of the stent is greater than
the balloon, reducing the overall gain may reduce the
acoustic noise of the balloon, which enhances the
borders of the stent. In more difﬁcult cases, live 3DFIGURE 13 Locating Catheters for TAVR
For self-expanding valve implantation, the pigtail catheter is positioned in
“lowest” sinus and thus allows the interventionalists to judge the positio
imaging view, the green arrow indicates the double lumen of the pigtail
NCC ¼ noncoronary cusp; TAVR ¼ transcatheter aortic valve replacemeimaging (Figure 11D, Online Video 2) may enhance
imaging of the stent by increasing the “depth of
ﬁeld.” Knowing the dimensions of the THV may be
important if the proximal and distal edges of the THV
cannot be clearly identiﬁed. The second generation
balloon-expandable valve shortens 3 mm during
deployment, primarily from the ventricular end, with
crimped lengths of 17 mm for the 23-mm XT, 20 mm
for the 26-mm XT, and 22 mm for 29-mm XT. The
third generation balloon-expandable valve crimped
heights are signiﬁcantly longer: 21 mm for the 20-mm
valve, 24.5 mm for the 23-mm valve, 27 mm for the
26-mm valve, and 31 mm for 29-mm valve.
To accurately position the balloon-expandable
valve understanding the operator-independent mo-
tion due to valve shortening is essential. Dvir et al.
(59) showed that during deployment, device upward
movement on ﬂuoroscopy was asymmetrical, occur-
ring more in the lower part of the device than in
its upper part (3.20  1.40 mm vs. 0.75  1.50 mm,
p < 0.001). This motion includes the normal short-
ening of the valve as it expands from the crimped
state to the fully deployed state. If the ideal ﬁnal
position of the inﬂow (proximal) edge of the ﬁrst
generation balloon-expandable valve or second gen-
eration balloon-expandable valve w2 mm below the
annulus and this edge of the valve moves 3 to 4 mm
superiorly, then the ideal echocardiographic position
of the valve during pacing should be w5 to 6 mm
below the annulus (Online Video 3). If the inﬂow or
proximal edge of the valve cannot be imaged, thenthe noncoronary sinus of Valsalva (SOV). Angiographically, this is the
n of the anterior edge of the device. In this simultaneous multiplane
catheter, positioned in the correct noncoronary SOV. LA ¼ left atrium;
nt.
FIGURE 14 Self-Expanding Valve Deployment
The self-expanding valve deployment is a slow and controlled process, which can be easily imaged by 2D as well as 3D transesophageal
echocardiography. (A) shows the initial unsheathing of the self-expanding valve with initial position of the lower edges indicated by the
red arrows. The edge of the sheath is indicated by the yellow arrow; leaﬂets are not yet unsheathed. (B) is the accompanying 3D image. In (C),
the valve has been positioned more superiorly and the lower (posterior) edge is now 5 mm below the annulus. The self-expanding valve leaﬂets
(blue arrow) are functioning and hemodynamics remain very stable. The aortic (outﬂow) end of the valve is not yet open (yellow arrow).
(D) is the accompanying 3D image (Online Video 5). The well-positioned and fully deployed valve is imaged in (E) (Online Video 6)
with the accompanying 3D image in (F). Abbreviations as in Figure 11.
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276positioning using the outﬂow or aortic edge of the
valve should be performed as described in the
following text for the third generation balloon-
expandable valve.
Sizing and positioning of the third generation
balloon-expandable valve is different than previous
iterations of the balloon-expandable valve. Because
of the outer skirt, the third generation balloon-
expandable valve does not require signiﬁcant over-
sizing. In fact, sizing algorithms for this valve suggest
that undersizing by up to 5% is acceptable, with little
to no resulting paravalvular regurgitation. The celldesign of this valve allows for shortening of the valve
only from the ventricular side. Thus, positioning
should focus primarily on the aortic or outﬂow end of
the valve (Figure 12). This distal edge of the stent
should cover the native leaﬂets but remain below the
sinotubular junction. Although biplane imaging is not
required, it can be useful on occasion to determine
the position of the valve in relation to the valve
opening and image the left main coronary during
deployment. Fluoroscopic imaging with contrast in-
jection is frequently used to conﬁrm the valve posi-
tion; however, just before actual valve deployment,
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277echocardiography can again be used to ensure
appropriate positioning (Online Video 4). In patients
with more limited annular or valvular calciﬁcation, or
with a heavily calciﬁed aortic root and mitral valve
annulus/LVOT, determining the optimal valve posi-
tion using ﬂuoroscopy alone can be challenging, and
more emphasis may be placed upon echocardio-
graphic information.
SELF-EXPANDING THV POSITIONING. Positioning of
the self-expanding valve is usually performed under
ﬂuoroscopic guidance primarily. Although this is
typically adequate, the use of TEE imaging as an
adjunct to ﬂuoroscopic imaging seems reasonable and
may improve procedural results with more rapidFIGURE 15 Transthoracic Imaging During THV Deployment
Transthoracic imaging can be used for monitoring during transcatheter
implantation, the initial parasternal long-axis view (A) (Online Video 7) s
following repositioning of the self-expanding valve to approximately 5
and a post-dilation, color Doppler simultaneous multiplane imaging (C)
(blue arrows). Note that although the inﬂow portion of the valve is ova
multiplane image in E with single plane short-axis color Doppler image
gitation. (Note: red dotted arrows indicate the level of imaging in the odiagnosis of complications while minimizing radia-
tion and contrast exposure.
Deployment of the self-expanding valve is typi-
cally a slow, controlled procedure. Because of the
curvature of the aorta, the valve will start noncoaxial
with the long axis of the aorta, the tip pointing pos-
teriorly and to the left. Echocardiography can be used
to conﬁrm the position of the pigtail catheter in the
noncoronary sinus of Valsalva (Figure 13). Ensuring
the position of the ventricular wire is also extremely
important for stabilizing deployment. Figure 8C
shows poor wire positioning before implantation of
a self-expanding valve with subsequent emboliza-
tion of the valve into the aorta. It is important tovalve deployment. In these images of a self-expanding valve
uggests the valve position is too low. (B) A magniﬁed long-axis view
mm below the annulus (yellow arrows). Following deployment
(Online Video 8) shows trace residual paravalvular regurgitation
l (D), imaging of the constrained portion of the valve (simultaneous
in F) show a circular valve with no evidence for central aortic regur-
rthogonal plane). THV ¼ transcatheter heart valve.
FIGURE 16 Assess
Biplane color Dopple
arteries. The short-a
ﬂow (yellow arrow ¼
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278remember that the imaging planes on TEE and
ﬂuoroscopy are very different. The optimal imaging
plane of ﬂuoroscopy typically cannot be obtained
from a TEE imaging position in the esophagus.
Because of this, the posterior edge of the THV
imaged on TEE is typically the edge between the
noncoronary and left coronary cusp, whereas the
posterior edge of the THV on ﬂuoroscopy is the
edge adjacent to the left coronary cusp.
Because of the posterolateral orientation of the
valve, when initial deployment begins, the posterior
edge of the THV is “higher” (more aortic) than the
anterior edge. Imaging should conﬁrm that this edge
is at least 4 mm (but not more than 10 mm) below the
annulus (Figure 14, Online Video 5). As the valve is
deployed, there is typically an operator-independent
reorientation of the valve to align more parallel to
the long axis of the aorta. The valve will typically
“pivot” on the posterior edge causing the anterior
edge of the THV to move more superiorly; this is the
justiﬁcation for positioning the valve initially based
on the location of this posterior THV edge. In cases
where the TEE probe obscures ﬂuoroscopy imaging of
the aortic valve/annulus, either another ﬂuoroscopic
angle or echocardiographic window can be attemp-
ted; a compromise position is sometimes required.
The ﬁnal valve position should be between 4 to 10
mm below the annular plane (Online Video 6). The
recommended positioning of the second generation
self-expanding transcatheter aortic valve is 3 to 5 mm
below the annular plane.
Transthoracic imaging support can be useful in the
setting of TAVR without general anesthesia. Figure 15ment of Coronary Artery Patency
r imaging can be used to rapidly assess the patency of the coronary
xis (SAX) view is the most important view for imaging coronary artery
left main coronary artery, red arrow ¼ right coronary artery).(Online Video 7) shows an example of repositioning of
the self-expanding valve on the basis of echocardio-
graphic imaging with post-implant assessment of
valve function (Online Video 8).
POST-PROCEDURAL
ECHOCARDIOGRAPHIC IMAGING
Although precise valve placement can be performed
with ﬂuoroscopic imaging alone, echocardiographic
imaging is essential in the immediate implantation
period. Following THV deployment, echocardio-
graphic imaging provides rapid and accurate assess-
ment of valve position, valve shape, leaﬂet motion,
and gradients. Color Doppler imaging provides
prompt and precise feedback to the interventionalists
about the presence, location, and severity of aortic
regurgitation, as well as coronary patency and mitral
valve function. In the setting of hemodynamic
compromise, potential etiologies such as left ven-
tricular/right ventricular dysfunction or aortic root
catastrophe can be assessed within seconds.
ASSESSING TRANSCATHETER VALVE FUNCTION.
Immediately after valve deployment, TAVR stent
positioning, shape, and leaﬂet motion can be rapidly
assessed with simultaneous multiplane imaging
mode. The long-axis view is best for determining the
ﬁnal valve position and initial assessment of aortic
regurgitation; however, multiple short-axis views are
essential for assessing ﬁnal valve shape, presence,
and severity of paravalvular and central aortic
regurgitation and patency of the left main coronary
artery (Figure 16). Thus, using the long-axis view as
the primary view, simultaneous multiplane imaging
allows rapid imaging of multiple short-axis landing
zone levels without moving the TEE probe or chang-
ing angular rotation (Figure 17, Online Videos 9, 10,
and 11). The disadvantage to any 3D modality, how-
ever, is lower frame rates. To optimize color Doppler
imaging of paravalvular jets, a frame rate of at least 10
Hz (or higher, depending on the heart rate) should be
obtained. Two-dimensional short-axis plane imaging
may still be required to maximize frame rates in the
setting of high heart rates.
ASSESSING AORTIC REGURGITATION. There are a
number of obvious differences between surgical and
transcatheter prosthetic valves that may result in
signiﬁcant differences in regurgitant jet anatomy
and physiology. Transcatheter valves have no
sewing ring and thus, for similar annular di-
mensions, may yield larger valve areas. This has in
fact been shown in a number of studies (77–79).
“Dehiscence,” by traditional deﬁnitions, will not
FIGURE 17 Utility of Simultaneous Multiplane Imaging for Multilevel Imaging of the
Landing Zone
Biplane imaging allows a rapid assessment of long-axis (LAX) and short-axis (SAX) views.
The red arrow in the LAX images indicates the plane of the corresponding SAX view.
(A) images the left ventricular outﬂow tract (LVOT) in the SAX view, allowing a rapid
assessment of paravalvular aortic regurgitation just below the level of the stent and within
the LVOT (Online Video 9). (B) images the transcatheter valve in SAX view and allows
immediate assessment of valve shape and leaﬂet motion (Online Video 10). (C) images
the aortic root in SAX, at the level of the left main coronary artery (white arrow)
(Online Video 11).
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279occur, although malposition or migration may occur.
With transcatheter valves, the native aortic valve
cusps and annulus are intact, reducing the space
around the stent. In addition, the skirt at the prox-
imal end of the THV is speciﬁcally designed to
reduce aortic regurgitation. When making intra-
procedural decisions about the severity of para-
valvular regurgitation immediately following THV
deployment, color Doppler imaging of regurgitation
should always be performed from both long-axis and
short-axis views that include the LVOT immediately
proximal to the stent to conﬁrm that jets enter the
left ventricle and are not caught by the skirt
(Figure 18). Short-axis views that image the entire
annular and subannular region are particularly
important because regurgitant jets may occur any-
where around the perimeter of the valve. Deep-
gastric views can be very useful in identifying the
location and size of the origin of particularly anterior
jets (which may be acoustically shadowed from the
mid-esophageal views), but jet area and length are
never used to grade regurgitant severity (80). A
multiwindow, multiparametric approach recom-
mended by multiple guidelines (8,80) must take into
account the total circumferential extent of the jets,
width of the jets at their origin, number of jets, path
of the jet, and presence of proximal ﬂow conver-
gence. In this elderly patient population, color
Doppler parameters are typically more useful than
other Doppler parameters (continuous wave Doppler
jet density, pressure half-time, or ﬂow reversal in the
aorta), given the atypical nature of the jets and the
ventricular and aortic compliance abnormalities.
Small paravalvular jets following TAVR may spon-
taneously regress over 10 to 15 min and require no
further intervention (81). If the severity of regurgi-
tation by qualitative and semiquantitative methods
fails to conﬁdently determine the severity of regur-
gitation, quantitative Doppler (with calculation of
regurgitation volume and regurgitant oriﬁce area) or
3D color Doppler planimetry of the vena contracta
areas can be performed. Three-dimensional echo-
cardiography may overcome the limitations of 2D
and standard Doppler measurements for quantifying
regurgitation (82–84). Studies have shown the
feasibility of measuring the 3D vena contracta in
native disease (83,85–87), as well as post-TAVR
(Figure 19, Online Video 12) (84).
Because the lower 4mm of the self-expanding valve
has an incomplete skirt, some eccentric regurgitant
jets may be imaged entering the LVOT from the
aortic root through the incomplete skirt. These jets
are directed into the center of the LVOT and are
more difﬁcult to quantify (88). Many of thesejets spontaneously regress as the nitinol frame ex-
pands acutely, and a decision to treat these jets should
be made following an extended waiting period.
ASSESSING PROSTHETIC VALVE AREA. Intrapro-
cedurally, TEE Doppler should be performed in the
FIGURE 18 Utility of Simultaneous Multiplane Imaging for Multiwindow Imaging
Mid-esophageal views as well as deep gastric views are used to assess the presence of paravalvular aortic regurgitation (PAR) following TAVR.
Although LAX views are helpful in the assessment of PAR, SAX views of the LVOT just below the THV are essential to show the number and
location of the regurgitant jets. (A and B) show 2 trivial PAR jets in SAX view with only 1 jet seen in LAX view. (C and D) show severe central
(intravalvular) regurgitation arising from 1 of the THV cusps (noncoronary). (E and F) show deep gastric views of the THV with multiple PAR
regurgitant jets. Importantly, the deep gastric view should primarily be used to assess number of jets and the size of the jet origin but jet area
and length are not used to quantify PAR. Abbreviations as in Figure 17.
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280deep-gastric view that optimally aligns the trans-
aortic ﬂow with the insonation beam. Although peak
and mean transaortic gradients should always be
recorded, these measurements are ﬂow dependent,
and use of ﬂow-independent measures of the valvefunction is preferred. These include the assessment
of EOA by the continuity equation or Doppler velocity
index. The Valve Academic Research Consortium
update outlines criteria to determine dysfunction for
the THV (Table 6) (8). These criteria may continue to
FIGURE 19 3D Color Doppler Quantiﬁcation of PAR
Color Doppler 3D volumes (Online Video 12) can be used to directly measure effective regurgitant oriﬁce area (EROA). In this multiplanar
reconstruction, double-oblique technique (A and B) is used to obtain an on-axis view of the small posterior paravalvular regurgitant jet (C,
yellow arrow) with the resulting EROA (D) of 7 mm2.
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281be reﬁned as clinical trial data and registries report
“normal” values for both balloon-expandable and
self-expanding valves (89,90).
An accurate calculation of LVOT stroke volume
following TAVR can be performed for the balloon-
expandable valve (91,92). Because of ﬂow accelera-
tion within the stented valve (91), pulsed wave
Doppler of the LVOT is performed with the pulsed
Doppler sample volume just apical to the proximal
edge of the stent (Figure 20, Online Video 13). The
LVOT diameter, thus, should also be measured just
apical to the proximal edge of the stent and measuring
the outer-to-outer stent diameter. This diameter
measurement has been shown to correlate best with
measurements of mean gradient (92). Continuous
wave Doppler across the THV is performed to conﬁrm
gradients and calculate valve area. If the LVOT diam-
eter cannot be accurately measured, the Doppler indexis recorded andmay be a useful measurement for long-
term follow-up of valve function. Recent reports of the
PARTNER trial suggest that the Doppler index in a
normal balloon-expandable valve should be >0.45
(89), although dysfunction may not be suspected until
the Doppler index is <0.35 (8). If the stent protrudes
into the LVOT cavity (failing to make contact with
surrounding tissue), particularly if ﬂow is seen around
the outside of the inﬂow stent, then stroke volume
measurements using the inner-to-inner stent diameter
at the level of the prosthetic leaﬂet hinge points should
be used, along with the pulsed wave Doppler at this
same level.
Initial studies of the self-expanding valve sug-
gested the LVOT diameter should be taken just below
the hinge points of the visible prosthetic leaﬂets,
measuring the inner-to-inner stent (93). Because the
inﬂow portion of the self-expanding valve is
TABLE 6 Transcatheter Aortic Prosthetic Valve Dysfunction From VARC-2 (8)
Prosthetic Aortic Valve Stenosis* Normal Mild Stenosis
Moderate–Severe
Stenosis
Quantitative parameters (ﬂow-dependent)†
Peak velocity <3 m/s 3–4 m/s >4 m/s
Mean gradient <20 mm Hg 20–40 mm Hg >40 mm Hg
Quantitative parameters (ﬂow-independent)
Doppler velocity index $0.35 0.35–0.25 <0.25
Effective oriﬁce area, cm2 for BSA $1.6 m2 >1.1 cm2 1.0–0.8 cm2 <0.8 cm2
Effective oriﬁce area, cm2 for
BSA < 1.6 m2
>0.9 cm2/m2 0.9–0.6 cm2/m2 <0.6 cm2/m2
PPM Insigniﬁcant Moderate Severe
EOA indexed (cm2/m2) for BMI <30 kg/m2 >0.85 cm2/m2 0.85–0.65 cm2/m2 <0.65 cm2/m2
EOA indexed (cm2/m2) BMI $30 kg/m2 >0.70 cm2/m2 0.90–0.60 cm2/m2 <0.60 cm2/m2
*In conditions of normal or near normal stroke volume (50 to 70 ml). †These parameters are more affected by
ﬂow, including concomitant aortic regurgitation.
BMI ¼ body mass index; BSA ¼ body surface area; EOA ¼ effective oriﬁce area; PPM ¼ prosthesis–patient
mismatch; VARC ¼ Valve Academic Research Consortium.
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282frequently very oval whereas the constrained portion
of the valve (at the level of the leaﬂets) is more cir-
cular (Figure 15) the use of the inner-to-inner diam-
eter at the level of the leaﬂets for this valve makes
intuitive sense. Recent trials, however, have used the
outer-to-outer edge of the ventricular edge of the
THV (3). Validation of this method compared with
previously described methods for calculating the EOA
of the self-expanding THV is lacking. It seems most
logical to use similar methods to the ones describedFIGURE 20 Accurate Calculation of LVOT Stroke Volume
The LVOT must be accurately measured for assessment of aortic regurg
diameter should be performed just apical to the most proximal edge of t
the outer-to-outer edge of the stent. Pulsed Doppler of the LVOT shou
systole, just apical to the most proximal edge of the THV stent. (B) (Onl
view with sample volume just proximal to the lower edge of the stentefor the balloon-expandable valve: the LVOT diameter
just apical to the lowest edge stent when there is good
apposition of the stent frame with the surrounding
tissue and appears circular in short-axis views, and
the inner-to-inner stent diameter at the level of the
leaﬂets when the lower stent frame protrudes into the
left ventricular cavity or is very oval (Figure 21).
COMPLICATIONS OF TAVR
The most critical use of echocardiography is the im-
mediate assessment of complications following THV
deployment (Table 5), and these are comprehensively
covered in subsequent articles in this issue.
Not infrequently, repeat imaging is directed at
addressing speciﬁc hemodynamic abnormalities
identiﬁed by the interventionalists, surgeon, or
anesthesiologist. These abnormalities include acute
changes in blood pressure (hypertension or hypo-
tension) or increase in pulmonary artery pressures.
Major bleeding may be manifest as underﬁlling of the
ventricle. Pericardial effusions may indicate localized
bleeding during transapical procedures, an aortic ca-
tastrophe, or right ventricular perforation by the
temporary pacing wire. Many TAVR patients have
small, hypertrophied, and “stiff” ventricles that
tolerate even small effusions poorly. So a prompt
diagnosis is crucial. Other rare complications, such as
ventricular septal defects, can be also be detected. Aitant volume as well as aortic valve area. Measurement of the LVOT
he THV stent (A, red arrow) in the long-axis (sagittal) view and from
ld be performed from deep gastric views with the sample volume in
ine Video 13) is the simultaneous multiplane image from deep gastric
d valve.
FIGURE 21 Accurate Calculation of LVOT Stroke Volume Using In-Stent Measurements
In the setting of a transcatheter valve positioned low into the LVOT, with stent edges not apposing the native tissue, an in-stent diameter and
maximum pressure gradient in-stent pulsed Doppler of ﬂow can be used to measure stroke volume (SV). In this example of a self-expanding
valve that is well positioned, the LVOT diameter performed in the usual method (just apical to the most proximal edge of the THV stent from
the outer-to-outer edge of the stent) is used with the systolic pulsed Doppler of the LVOT just apical to the most proximal edge of the THV
stent (A); the stroke volume ¼ 52 ml (B). In (C), the in-stent diameter, measured from inner-to-inner edge of the stent at the level of the
leaﬂets, is used with the systolic pulsed Doppler of the LVOT within the stent (at the level of the THV leaﬂets) (C); the stroke volume ¼ 57 ml
(D). Max PG ¼ maximum pressure gradient; Mean PG ¼ mean pressure gradient; VTI ¼ velocity time integral; other abbreviations as in
Figures 1 and 6.
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283repeat complete TEE imaging protocol will detect all
these complications and is typically performed on
every patient.
FUTURE IMAGING CONSIDERATIONS
A number of advancements in imaging technology
may have utility during the TAVR procedure.
INTRACARDIAC ECHOCARDIOGRAPHY. Intracardiac
echocardiography (ICE) imaging is an attractive
alternative to TEE imaging given the proximity of the
structures imaged, the elimination of general anes-
thesia, and the ability of the interventionalists tocontrol the imaging acquisition (94–96). A review
article by Kim et al. (95) outlines the properties of an
ideal intracardiac imaging system for guiding cardiac
interventions. These properties included real-time 3D
imaging, adequate near-ﬁeld and far-ﬁeld imaging,
and no interference with the execution of the inter-
vention. ICE imaging has been proposed as an
acceptable alternative to TEE imaging during TAVR
(97–99). ICE measurement of the anteroposterior
diameter of the annulus was highly correlative
but underestimated TEE measurements (r ¼ 0.90,
p < 0.001) (98), as well as MSCT measurements
(r2 ¼ 0.82, p < 0.001) (99). Single-plane annular
measurements, visualization of the coronary ostia,
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284and post-procedural assessment of aortic regurgita-
tion can be performed using ICE and is reportedly
comparable to 2D TEE (100) but requires training and
standardization of views (101). As new ICE catheters
with greater 3D and Doppler capabilities are devel-
oped, the application of this imaging technique in
structural heart disease interventions will warrant
further investigation.
FUSION IMAGING. Co-registration of the echocar-
diographic images onto the ﬂuoroscopic image is now
feasible (102–104) and may be useful for many struc-
tural heart disease interventions. Positioning with a
combination of ﬂuoroscopic and echocardiographic
images may reduce contrast load or ﬂuoroscopy time
and reduce malpositioning. This new technology is
still under development, but further studies using
this technology should be performed.
CONCLUSIONS
The role of echocardiographic imaging for trans-
catheter valve implantation is multifaceted, requiring
expertise in both TTE and TEE imaging. Three-
dimensional technology is used extensively for ac-
curacy and expediency. Pre-procedural imaging is
the primary method of determining the severityof valvular disease and characterizing the complex
anatomy of the entire valve complex. In addition,
without a full pre-procedural assessment of car-
diac structure and function, recognizing changes
following TAVR becomes difﬁcult. Intraprocedural
imaging conﬁrms the annular and aortic measure-
ments, assesses the success and complications of
BAV, and assists in catheter and THV positioning.
Following THV deployment, TEE imaging provides
rapid and accurate assessment of valve position and
function, coronary patency, and mitral valve and
ventricular function. Post-procedural imaging is an
essential component of assessing the presence of
complications from the procedure.
Echocardiography has become an integral part of
the TAVR procedure, and echocardiographers have
become a vital part of the multidisciplinary TAVR
team. A comprehensive understanding of the role of
imaging throughout the procedure increases the
likelihood of procedural success.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Rebecca T. Hahn, Columbia University Medical Cen-
ter, 161 Fort Washington Avenue, PH3-342, New York,
New York 10032. E-mail: rth2@columbia.edu OR
rth2@cumc.columbia.edu.RE F E RENCE S1. Leon MB, Smith CR, Mack M, et al. Trans-
catheter aortic-valve implantation for aortic ste-
nosis in patients who cannot undergo surgery.
N Engl J Med 2010;363:1597–607.
2. Smith CR, Leon MB, Mack MJ, et al. Trans-
catheter versus surgical aortic-valve replacement
in high-risk patients. N Engl J Med 2011;364:
2187–98.
3. Adams DH, Popma JJ, Reardon MJ, et al.
Transcatheter aortic-valve replacement with a
self-expanding prosthesis. N Engl J Med 2014;
370:1790–8.
4. Popma JJ, Adams DH, Reardon MJ, et al.
Transcatheter aortic valve replacement using a
self-expanding bioprosthesis in patients with se-
vere aortic stenosis at extreme risk for surgery.
J Am Coll Cardiol 2014;63:1972–81.
5. Holmes DR Jr., Mack MJ, Kaul S, et al. 2012
ACCF/AATS/SCAI/STS expert consensus document
on transcatheter aortic valve replacement. J Am
Coll Cardiol 2012;59:1200–54.
6. Nishimura RA, Otto CM, Bonow RO, et al. 2014
AHA/ACC guideline for the management of pa-
tients with valvular heart disease: a report of the
American College of Cardiology/American Heart
Association Task Force on Practice Guidelines.
J Am Coll Cardiol 2014;63:e57–185.
7. Baumgartner H, Hung J, Bermejo J, et al.
Echocardiographic assessment of valve stenosis:EAE/ASE recommendations for clinical practice.
J Am Soc Echocardiogr 2009;22:1–23, quiz 101–2.
8. Kappetein AP, Head SJ, Genereux P, et al.
Updated standardized endpoint deﬁnitions for
transcatheter aortic valve implantation: the Valve
Academic Research Consortium-2 consensus
document. J Am Coll Cardiol 2012;60:1438–54.
9. Greif M, Lange P, Nabauer M, et al. Trans-
cutaneous aortic valve replacement with the
Edwards SAPIEN XT and Medtronic CoreValve
prosthesis under ﬂuoroscopic guidance and local
anaesthesia only. Heart 2014;100:691–5.
10. Durand E, Borz B, Godin M, et al. Transfemoral
aortic valve replacement with the Edwards SAPIEN
and Edwards SAPIEN XT prosthesis using exclu-
sively local anesthesia and ﬂuoroscopic guidance:
feasibility and 30-day outcomes. J Am Coll Cardiol
Intv 2012;5:461–7.
11. Motloch LJ, Rottlaender D, Reda S, et al. Local
versus general anesthesia for transfemoral aortic
valve implantation. Clin Res Cardiol 2012;101:
45–53.
12. Yamamoto M, Meguro K, Mouillet G, et al.
Effect of local anesthetic management with
conscious sedation in patients undergoing trans-
catheter aortic valve implantation. Am J Cardiol
2013;111:94–9.
13. Babaliaros V, Devireddy C, Lerakis S, et al.
Comparison of transfemoral transcatheter aorticvalve replacement performed in the catheteriza-
tion laboratory (minimalist approach) versus
hybrid operating room (standard approach): out-
comes and cost analysis. J Am Coll Cardiol Intv
2014;7:898–904.
14. Kodali SK, Williams MR, Smith CR, et al. Two-
year outcomes after transcatheter or surgical
aortic-valve replacement. N Engl J Med 2012;366:
1686–95.
15. Klein AA, Skubas NJ, Ender J. Controversies
and complications in the perioperative manage-
ment of transcatheter aortic valve replacement.
Anesth Analg 2014;119:784–98.
16. Hahn RT, Abraham T, Adams MS, et al.
Guidelines for performing a comprehensive
transesophageal echocardiographic examination:
recommendations from the American Society of
Echocardiography and the Society of Cardiovas-
cular Anesthesiologists. J Am Soc Echocardiogr
2013;26:921–64.
17. Pendyala LK, Minha S, Barbash IM, et al.
Commercial versus PARTNER study experience
with the transfemoral Edwards SAPIEN valve for
inoperable patients with severe aortic stenosis.
Am J Cardiol 2014;113:342–7.
18. Nishimura RA, Otto CM, Bonow RO, et al. 2014
AHA/ACC guideline for the management of pa-
tients with valvular heart disease: executive sum-
mary: a report of the American College of
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5 Hahn et al.
M A R C H 2 0 1 5 : 2 6 1 – 8 7 Echo Imaging in TAVR
285Cardiology/American Heart Association Task Force
on Practice Guidelines. J Am Coll Cardiol 2014;63:
2438–88.
19. Barbanti M, Yang TH, Rodès Cabau J, et al.
Anatomical and procedural features associated
with aortic root rupture during balloon-
expandable transcatheter aortic valve replace-
ment. Circulation 2013;128:244–53.
20. Binder RK, Webb JG, Willson AB, et al. The
impact of integration of a multidetector computed
tomography annulus area sizing algorithm on
outcomes of transcatheter aortic valve replace-
ment: a prospective, multicenter, controlled trial.
J Am Coll Cardiol 2013;62:431–8.
21. Willson AB, Webb JG, Freeman M, et al.
Computed tomography-based sizing recommen-
dations for transcatheter aortic valve replacement
with balloon-expandable valves: comparison with
transesophageal echocardiography and rationale
for implementation in a prospective trial.
J Cardiovasc Comput Tomogr 2012;6:406–14.
22. Barbanti M, Leipsic J, Binder R, et al. Under-
expansion and ad hoc post-dilation in selected
patients undergoing balloon-expandable trans-
catheter aortic valve replacement. J Am Coll Car-
diol 2014;63:976–81.
23. Amat-Santos IJ, Dahou A, Webb J, et al.
Comparison of hemodynamic performance of the
balloon-expandable SAPIEN 3 versus SAPIEN XT
transcatheter valve. Am J Cardiol 2014;114:
1075–82.
24. Webb J, Gerosa G, Lefevre T, et al. Multicenter
evaluation of a next-generation balloon-expand-
able transcatheter aortic valve. J Am Coll Cardiol
2014;64:2235–43.
25. Achenbach S, Delgado V, Hausleiter J,
Schoenhagen P, Min JK, Leipsic JA. SCCT expert
consensus document on computed tomography
imaging before transcatheter aortic valve implan-
tation (TAVI)/transcatheter aortic valve replace-
ment (TAVR). J Cardiovasc Comput Tomogr 2012;
6:366–80.
26. Blanke P, Willson AB, Webb JG, et al. Over-
sizing in transcatheter aortic valve replacement, a
commonly used term but a poorly understood one:
dependency on deﬁnition and geometrical mea-
surements. J Cardiovasc Comput Tomogr 2014;8:
67–76.
27. Zoghbi WA, Enriquez-Sarano M, Foster E, et al.
Recommendations for evaluation of the severity
of native valvular regurgitation with two-
dimensional and Doppler echocardiography. J Am
Soc Echocardiogr 2003;16:777–802.
28. Athappan G, Patvardhan E, Tuzcu EM, et al.
Incidence, predictors, and outcomes of aortic
regurgitation after transcatheter aortic valve
replacement: meta-analysis and systematic review
of literature. J Am Coll Cardiol 2013;61:1585–95.
29. Ribeiro HB, Nombela-Franco L, Urena M, et al.
Coronary obstruction following transcatheter
aortic valve implantation: a systematic review.
J Am Coll Cardiol Intv 2013;6:452–61.
30. Detaint D, Lepage L, Himbert D, et al. De-
terminants of signiﬁcant paravalvular regurgita-
tion after transcatheter aortic valve: implantation
impact of device and annulus discongruence. J Am
Coll Cardiol Intv 2009;2:821–7.31. Piazza N, de Jaegere P, Schultz C, Becker AE,
Serruys PW, Anderson RH. Anatomy of the aortic
valvar complex and its implications for trans-
catheter implantation of the aortic valve. Circ
Cardiovasc Interv 2008;1:74–81.
32. Tzikas A, Schultz CJ, Piazza N, et al.
Assessment of the aortic annulus by multislice
computed tomography, contrast aortography,
and trans-thoracic echocardiography in patients
referred for transcatheter aortic valve implan-
tation. Catheter Cardiovasc Interv 2011;77:
868–75.
33. Koos R, Altiok E, Mahnken AH, et al. Evalua-
tion of aortic root for deﬁnition of prosthesis size
by magnetic resonance imaging and cardiac
computed tomography: implications for trans-
catheter aortic valve implantation. Int J Cardiol
2012;158:353–8.
34. Altiok E, Koos R, Schroder J, et al. Com-
parison of two-dimensional and three-dimensional
imaging techniques for measurement of aortic
annulus diameters before transcatheter aortic
valve implantation. Heart 2011;97:1578–84.
35. Hamdan A, Guetta V, Konen E, et al. Defor-
mation dynamics and mechanical properties of the
aortic annulus by 4-dimensional computed to-
mography insights into the functional anatomy of
the aortic valve complex and implications for
transcatheter aortic valve therapy. J Am Coll
Cardiol 2012;59:119–27.
36. Willson AB, Webb JG, Labounty TM, et al.
3-dimensional aortic annular assessment by mul-
tidetector computed tomography predicts mod-
erate or severe paravalvular regurgitation after
transcatheter aortic valve replacement: a multi-
center retrospective analysis. J Am Coll Cardiol
2012;59:1287–94.
37. Jilaihawi H, Kashif M, Fontana G, et al. Cross-
sectional computed tomographic assessment im-
proves accuracy of aortic annular sizing for
transcatheter aortic valve replacement and re-
duces the incidence of paravalvular aortic regur-
gitation. J Am Coll Cardiol 2012;59:1275–86.
38. Gurvitch R, Webb JG, Yuan R, et al. Aortic
annulus diameter determination by multidetector
computed tomography: reproducibility, applica-
bility, and implications for transcatheter aortic
valve implantation. J Am Coll Cardiol Intv 2011;4:
1235–45.
39. Hahn RT, Khalique O, Williams MR, et al. Pre-
dicting paravalvular regurgitation following
transcatheter valve replacement: utility of a novel
method for three-dimensional echocardiographic
measurements of the aortic annulus. J Am Soc
Echocardiogr 2013;26:1043–52.
40. Santos N, de Agustin JA, Almeria C, et al.
Prosthesis/annulus discongruence assessed by
three-dimensional transoesophageal echocardi-
ography: a predictor of signiﬁcant paravalvular
aortic regurgitation after transcatheter aortic
valve implantation. Eur Heart J Cardiovasc Imag-
ing 2012;13:931–7.
41. Janosi RA, Kahlert P, Plicht B, et al. Measure-
ment of the aortic annulus size by real-time three-
dimensional transesophageal echocardiography.
Minim Invasive Ther Allied Technol 2011;20:
85–94.42. Tsang W, Bateman MG, Weinert L, et al. Ac-
curacy of aortic annular measurements obtained
from three-dimensional echocardiography, CT and
MRI: human in vitro and in vivo studies. Heart
2012;98:1146–52.
43. Gripari P, Ewe SH, Fusini L, et al. Intra-
operative 2D and 3D transoesophageal echocar-
diographic predictors of aortic regurgitation after
transcatheter aortic valve implantation. Heart
2012;98:1229–36.
44. Smith LA, Dworakowski R, Bhan A, et al. Real-
time three-dimensional transesophageal echocar-
diography adds value to transcatheter aortic valve
implantation. J Am Soc Echocardiogr 2013;26:
359–69.
45. Jilaihawi H, Doctor N, Kashif M, et al. Aortic
annular sizing for transcatheter aortic valve
replacement using cross-sectional 3-dimensional
transesophageal echocardiography. J Am Coll
Cardiol 2013;61:908–16.
46. Khalique OK, Kodali SK, Paradis JM, et al.
Aortic annular sizing using a novel 3-dimensional
echocardiographic method: use and comparison
with cardiac computed tomography. Circ Car-
diovasc Imaging 2014;7:155–63.
47. Kasel AM, Cassese S, Bleiziffer S, et al. Stan-
dardized imaging for aortic annular sizing: impli-
cations for transcatheter valve selection. J Am Coll
Cardiol Img 2013;6:249–62.
48. Burgstahler C, Kunze M, Lofﬂer C, Gawaz MP,
Hombach V, Merkle N. Assessment of left ven-
tricular outﬂow tract geometry in non-stenotic
and stenotic aortic valves by cardiovascular mag-
netic resonance. J Cardiovasc Magn Reson 2006;
8:825–9.
49. Doddamani S, Bello R, Friedman MA, et al.
Demonstration of left ventricular outﬂow tract
eccentricity by real time 3D echocardiography:
implications for the determination of aortic valve
area. Echocardiography 2007;24:860–6.
50. De Vecchi C, Caudron J, Dubourg B, et al.
Effect of the ellipsoid shape of the left
ventricular outﬂow tract on the echocardio-
graphic assessment of aortic valve area in aortic
stenosis. J Cardiovasc Comput Tomogr 2014;8:
52–7.
51. Montealegre-Gallegos M, Mahmood F,
Owais K, Hess P, Jainandunsing JS, Matyal R.
Cardiac output calculation and three-dimensional
echocardiography. J Cardiothorac Vasc Anesth
2014;28:547–50.
52. Saitoh T, Shiota M, Izumo M, et al. Comparison
of left ventricular outﬂow geometry and aortic
valve area in patients with aortic stenosis by 2-
dimensional versus 3-dimensional echocardiogra-
phy. Am J Cardiol 2012;109:1626–31.
53. Gaspar T, Adawi S, Sachner R, et al. Three-
dimensional imaging of the left ventricular
outﬂow tract: impact on aortic valve area esti-
mation by the continuity equation. J Am Soc
Echocardiogr 2012;25:749–57.
54. Malouf J, Le Tourneau T, Pellikka P, et al.
Aortic valve stenosis in community medical prac-
tice: determinants of outcome and implications for
aortic valve replacement. J Thorac Cardiovasc Surg
2012;144:1421–7.
Hahn et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5
Echo Imaging in TAVR M A R C H 2 0 1 5 : 2 6 1 – 8 7
28655. Nishimura RA, Otto C. 2014 ACC/AHA valve
guidelines: earlier intervention for chronic mitral
regurgitation. Heart 2014;100:905–7.
56. Masson JB, Kovac J, Schuler G, et al. Trans-
catheter aortic valve implantation: review of the
nature, management, and avoidance of procedural
complications. J Am Coll Cardiol Intv 2009;2:
811–20.
57. Ewe SH, Ng AC, Schuijf JD, et al. Location and
severity of aortic valve calcium and implications
for aortic regurgitation after transcatheter aortic
valve implantation. Am J Cardiol 2011;108:1470–7.
58. Khalique OK, Hahn RT, Gada H, et al. Quantity
and location of aortic valve complex calciﬁcation
predicts severity and location of paravalvular
regurgitation and frequency of post-dilation after
balloon-expandable transcatheter aortic valve
replacement. JAmColl Cardiol Intv2014;7:885–94.
59. Dvir D, Lavi I, Eltchaninoff H, et al. Multicenter
evaluation of Edwards SAPIEN positioning during
transcatheter aortic valve implantation with cor-
relates for device movement during ﬁnal deploy-
ment. J Am Coll Cardiol Intv 2012;5:563–70.
60. Haensig M, Lehmkuhl L, Rastan AJ, et al. Aortic
valve calcium scoring is a predictor of signiﬁcant
paravalvular aortic insufﬁciency in transapical-
aortic valve implantation. Eur J Cardiothorac Surg
2012;41:1234–40, discussion 1240–1.
61. Feuchtner G, Plank F, Bartel T, et al. Prediction
of paravalvular regurgitation after transcatheter
aortic valve implantation by computed tomogra-
phy: value of aortic valve and annular calciﬁcation.
Ann Thorac Surg 2013;96:1574–80.
62. Colli A, D’Amico R, Kempfert J, Borger MA,
Mohr FW, Walther T. Transesophageal echocar-
diographic scoring for transcatheter aortic valve
implantation: impact of aortic cusp calciﬁcation on
postoperative aortic regurgitation. J Thorac Car-
diovasc Surg 2011;142:1229–35.
63. Genereux P, Reiss GR, Kodali SK, Williams MR,
Hahn RT. Periaortic hematoma after transcatheter
aortic valve replacement: description of a new
complication. Catheter Cardiovasc Interv 2012;79:
766–76.
64. Leber AW, Kasel M, Ischinger T, et al. Aortic
valve calcium score as a predictor for outcome
after TAVI using the CoreValve revalving system.
Int J Cardiol 2013;166:652–7.
65. Hayashida K, Bouvier E, Lefevre T, et al.
Transcatheter aortic valve implantation for pa-
tients with severe bicuspid aortic valve stenosis.
Circ Cardiovasc Interv 2013;6:284–91.
66. Kochman J, Huczek Z, Scislo P, et al. Com-
parison of one- and 12-month outcomes of
transcatheter aortic valve replacement in patients
with severely stenotic bicuspid versus tricuspid
aortic valves (results from a multicenter registry).
Am J Cardiol 2014;114:757–62.
67. Wijesinghe N, Ye J, Rodés-Cabau J, et al.
Transcatheter aortic valve implantation in patients
with bicuspid aortic valve stenosis. J Am Coll
Cardiol Intv 2010;3:1122–5.
68. Ferrari E, Locca D, Sulzer C, et al. Successful
transapical aortic valve implantation in a congen-
ital bicuspid aortic valve. Ann Thorac Surg 2010;
90:630–2.69. Chiam PT, Chao VT, Tan SY, et al. Percuta-
neous transcatheter heart valve implantation in a
bicuspid aortic valve. J Am Coll Cardiol Intv 2010;
3:559–61.
70. Mylotte D, Lefevre T, Sondergaard L, et al.
Transcatheter aortic valve replacement in bicuspid
aortic valve disease. J Am Coll Cardiol 2014;64:
2330–9.
71. Sievers HH, Schmidtke C. A classiﬁcation sys-
tem for the bicuspid aortic valve from 304 surgical
specimens. J Thorac Cardiovasc Surg 2007;133:
1226–33.
72. Messika-Zeitoun D, Serfaty JM, Brochet E,
et al. Multimodal assessment of the aortic annulus
diameter: implications for transcatheter aortic
valve implantation. J Am Coll Cardiol 2010;55:
186–94.
73. Leipsic J, Gurvitch R, Labounty TM, et al.
Multidetector computed tomography in trans-
catheter aortic valve implantation. J Am Coll
Cardiol Img 2011;4:416–29.
74. Babaliaros VC, Liff D, Chen EP, et al. Can
balloon aortic valvuloplasty help determine
appropriate transcatheter aortic valve size? J Am
Coll Cardiol Intv 2008;1:580–6.
75. Patsalis PC, Al-Rashid F, Neumann T, et al.
Preparatory balloon aortic valvuloplasty during
transcatheter aortic valve implantation for
improved valve sizing. J Am Coll Cardiol Intv 2013;
6:965–71.
76. Ben-Dor I, Pichard AD, Satler LF, et al. Com-
plications and outcome of balloon aortic valvulo-
plasty in high-risk or inoperable patients. J Am
Coll Cardiol Intv 2010;3:1150–6.
77. Clavel MA, Webb JG, Pibarot P, et al. Com-
parison of the hemodynamic performance of
percutaneous and surgical bioprostheses for the
treatment of severe aortic stenosis. J Am Coll
Cardiol 2009;53:1883–91.
78. Clavel MA, Webb JG, Rodés-Cabau J, et al.
Comparison between transcatheter and surgical
prosthetic valve implantation in patients with se-
vere aortic stenosis and reduced left ventricular
ejection fraction. Circulation 2010;122:1928–36.
79. Pibarot P, Weissman NJ, Stewart WJ, et al.
Incidence and sequelae of prosthesis-patient
mismatch in transcatheter versus surgical valve
replacement in high-risk patients with severe
aortic stenosis: a PARTNER trial cohort—a analysis.
J Am Coll Cardiol 2014;64:1323–34.
80. Zoghbi WA, Chambers JB, Dumesnil JG, et al.
Recommendations for evaluation of prosthetic
valves with echocardiography and Doppler ultra-
sound: a report from the American Society of
Echocardiography’s Guidelines and Standards
Committee and the Task Force on Prosthetic
Valves, developed in conjunction with the Amer-
ican College of Cardiology Cardiovascular Imaging
Committee, Cardiac Imaging Committee of the
American Heart Association, the European Asso-
ciation of Echocardiography, a registered branch
of the European Society of Cardiology, the Japa-
nese Society of Echocardiography and the Cana-
dian Society of Echocardiography, endorsed by the
American College of Cardiology Foundation,
American Heart Association, European Association
of Echocardiography, a registered branch of theEuropean Society of Cardiology, the Japanese
Society of Echocardiography, and Canadian Soci-
ety of Echocardiography. J Am Soc Echocardiogr
2009;22:975–1014, quiz 82–4.
81. Daneault B, Koss E, Hahn RT, et al. Efﬁcacy
and safety of postdilatation to reduce paravalvular
regurgitation during balloon-expandable trans-
catheter aortic valve replacement. Circ Cardiovasc
Interv 2013;6:85–91.
82. Lang RM, Badano LP, Tsang W, et al. EAE/ASE
recommendations for image acquisition and
display using three-dimensional echocardiogra-
phy. J Am Soc Echocardiogr 2012;25:3–46.
83. Perez de Isla L, Zamorano J, Fernandez-Golﬁn C,
et al. 3D color-Doppler echocardiography and
chronic aortic regurgitation: a novel approach for
severity assessment. Int J Cardiol 2013;166:640–5.
84. Goncalves A, Almeria C, Marcos-Alberca P,
et al. Three-dimensional echocardiography in
paravalvular aortic regurgitation assessment after
transcatheter aortic valve implantation. J Am Soc
Echocardiogr 2012;25:47–55.
85. Mori Y, Shiota T, Jones M, et al. Three-
dimensional reconstruction of the color Doppler-
imaged vena contracta for quantifying aortic
regurgitation: studies in a chronic animal model.
Circulation 1999;99:1611–7.
86. Fang L, Hsiung MC, Miller AP, et al. Assess-
ment of aortic regurgitation by live three-
dimensional transthoracic echocardiographic
measurements of vena contracta area: usefulness
and validation. Echocardiography 2005;22:775–81.
87. Pirat B, Little SH, Igo SR, et al. Direct mea-
surement of proximal isovelocity surface area by
real-time three-dimensional color Doppler for
quantitation of aortic regurgitant volume: an
in vitro validation. J Am Soc Echocardiogr 2009;
22:306–13.
88. Abdel-Wahab M, Mehilli J, Frerker C, et al.
Comparison of balloon-expandable vs self-
expandable valves in patients undergoing trans-
catheter aortic valve replacement: the CHOICE
randomized clinical trial. JAMA 2014;311:1503–14.
89. Hahn RT, Pibarot P, Stewart WJ, et al. Com-
parison of transcatheter and surgical aortic valve
replacement in severe aortic stenosis: a longitu-
dinal study of echocardiography parameters in
cohort A of the PARTNER trial (Placement of
Aortic Transcatheter Valves). J Am Coll Cardiol
2013;61:2514–21.
90. Nombela-Franco L, Ruel M, Radhakrishnan S,
et al. Comparison of hemodynamic performance of
self-expandable CoreValve versus balloon-
expandable Edwards SAPIEN aortic valves inser-
ted by catheter for aortic stenosis. Am J Cardiol
2013;111:1026–33.
91. Shames S, Koczo A, Hahn R, Gillam LD.
In-stent ﬂow acceleration in the SAPIEN trans-
catheter aortic valve: impact on the echocardio-
graphic assessment of valve function (P3–28).
J Am Soc Echocardiogr 2011;24:B63.
92. Clavel MA, Rodes-Cabau J, Dumont E, et al.
Validation and characterization of transcatheter
aortic valve effective oriﬁce area measured by
Doppler echocardiography. J Am Coll Cardiol Img
2011;4:1053–62.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5 Hahn et al.
M A R C H 2 0 1 5 : 2 6 1 – 8 7 Echo Imaging in TAVR
28793. Jilaihawi H, Chin D, Spyt T, et al. Prosthesis-
patient mismatch after transcatheter aortic valve
implantation with the Medtronic-Corevalve bio-
prosthesis. Eur Heart J 2010;31:857–64.
94. Asrress KN, Mitchell AR. Intracardiac echo-
cardiography. Heart 2009;95:327–31.
95. Kim SS, Hijazi ZM, Lang RM, Knight BP. The
use of intracardiac echocardiography and other
intracardiac imaging tools to guide noncoronary
cardiac interventions. J Am Coll Cardiol 2009;53:
2117–28.
96. Hijazi ZM, Shivkumar K, Sahn DJ. Intracardiac
echocardiography during interventional and elec-
trophysiological cardiac catheterization. Circula-
tion 2009;119:587–96.
97. Vaina S, Ligthart J, Vijayakumar M, et al. Intra-
cardiac echocardiography during interventional
procedures. EuroIntervention 2006;1:454–64.98. Bartel T, Bonaros N, Muller L, et al. Intracar-
diac echocardiography: a new guiding tool for
transcatheter aortic valve replacement. J Am Soc
Echocardiogr 2011;24:966–75.
99. Ussia GP, Barbanti M, Sarkar K, et al. Accuracy
of intracardiac echocardiography for aortic root
assessment in patients undergoing transcatheter
aortic valve implantation. Am Heart J 2012;163:
684–9.
100. Bartel T, Bonaros N, Edlinger M, et al.
Intracardiac echo and reduced radiocontrast re-
quirements during TAVR. J Am Coll Cardiol Img
2014;7:319–20.
101. Bartel T, Muller S, Biviano A, Hahn RT. Why is
intracardiac echocardiography helpful? Beneﬁts,
costs, and how to learn. EurHeart J 2014;35:69–76.
102. Gao G, Penney G, Ma Y, et al. Registration of
3D trans-esophageal echocardiography to X-rayﬂuoroscopy using image-based probe tracking.
Med Image Anal 2012;16:38–49.
103. Lang P, Seslija P, Chu MW, et al.
US-ﬂuoroscopy registration for transcatheter
aortic valve implantation. IEEE Trans Biomed Eng
2012;59:1444–53.
104. Mountney P, Ionasec R, Kaizer M, et al.
Ultrasound and ﬂuoroscopic images fusion by
autonomous ultrasound probe detection. Med Im-
age Comput Comput Assist Interv 2012;15 Pt 2:
544–51.
KEY WORDS aortic stenosis, aortic valve,
echocardiography, TAVR
APPENDIX For supplemental videos,
please see the online version of this paper.
